Balanced news tone
News Sentiment
BIIB sentiment intelligence
Biogen Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
55
Balanced news tone
41 relevant articles
News tone and price action are not far from neutral.
79/100 classification confidence.
directly relevant articles
high-authority source matches
+2.4% over one week, +3.7% over four weeks, trend active, and near fair-value range.
Biogen to acquire RayThera for up to $1bn
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
79/100 classification
One-week reaction
2.4%
Price confirming higher
Trend fit
Trend active
3.7% over four weeks
Fair value
4.7%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
16
Neutral
22
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
simplywall.st
Direct company coverage
Biogen (BIIB) One Off US$1.1b Loss Tests Bullish Earnings Growth Narrative
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- simplywall.st
TradingView
Direct company coverage
Biogen Q1 Earnings: Can New Launches Offset Declining MS Franchise?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Apr 2026 07:00
- Source
- TradingView
Market source
Direct company coverage
Biogen (BIIB) Stock Trades Up, Here Is Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Should Value Investors Buy Biogen (BIIB) Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- Market source
StockStory
Direct company coverage
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- StockStory
The Economic Times
Direct company coverage
US Stocks: Apellis shares double on Biogen's $5.6 billion buyout plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Mar 2026 07:00
- Source
- The Economic Times
The Economic Times
Direct company coverage
US Stocks: Biogen gets FDA approval for higher dose of genetic disorder drug, shares rise 3%
- Tone
- Positive 66/100
- Event
- Regulatory and legal
- Published
- 30 Mar 2026 07:00
- Source
- The Economic Times
simplywall.st
Direct company coverage
There May Be Reason For Hope In Biogen's (NASDAQ:BIIB) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 13 Feb 2026 08:00
- Source
- simplywall.st
TradingView
Direct company coverage
New Drugs Take Center Stage as Biogen Heads Into Q4 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Feb 2026 08:00
- Source
- TradingView
CNBC
Direct company coverage
Stocks making the biggest moves midday: Biogen, Rivian, Bank of America, Airbnb & more
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jan 2026 08:00
- Source
- CNBC
simplywall.st
Direct company coverage
Has C4 Therapeutics’ (CCCC) Biogen Partnership Become a Defining Test of Its Collaborative Model?
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 17 Sep 2025 07:00
- Source
- simplywall.st